| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | BX-912 | GDSC1000 | pan-cancer | AAC | 0.097 | 0.001 |
| mRNA | PD-0325901 | CCLE | pan-cancer | AAC | -0.14 | 0.001 |
| mRNA | TG-100-115 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.001 |
| mRNA | BRD-K28456706 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | tretinoin:navitoclax (4:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.11 | 0.002 |
| mRNA | WAY-362450 | CTRPv2 | pan-cancer | AAC | 0.12 | 0.002 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.002 |
| mRNA | ABT-199 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.002 |
| mRNA | BRD-K44224150 | CTRPv2 | pan-cancer | AAC | 0.23 | 0.002 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.003 |